A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Détails bibliographiques
Auteur principal:	Shehab, Habibul Mohsin
Autres auteurs:	Yasmin, Hasina
Format:	Thèse
Langue:	English
Publié:	Brac University 2024
Sujets:	Pharmacovigilance Rivastigmine Alzheimer's disease Dementia Pharmacoepidemiology. Mortality. Alzheimer's disease.
Accès en ligne:	http://hdl.handle.net/10361/22683

Documents similaires

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
par: Tabassum, Nadira
Publié: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
par: Mahee, Sadique Abdal
Publié: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
par: Alim, Abdul
Publié: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
par: Karmaker, Swastika
Publié: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
par: Jahan, Nusrat
Publié: (2023)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
par: Ishrat, Nowshin
Publié: (2024)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
par: Bakar, Osama Bin Abu
Publié: (2024)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
par: Chowdhury, Sariya Uzrat
Publié: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
par: Islam, Md. Irfath
Publié: (2023)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
par: Saha, Bithi Rani
Publié: (2023)

Alzheimer's disease and marriage : an intimate account /
par: Wright, Lore K.
Publié: (1993)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
par: Hassan, Md. Muhtaz
Publié: (2020)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
par: Tasneem, Sadia
Publié: (2021)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
par: Tamanna, Mst. Taskia
Publié: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
par: Tasin, Md Abtahi
Publié: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
par: Aziz, Farhin
Publié: (2019)

An ambient assisted living system for Alzheimer’s patients
par: Abedin, Minhajul, et autres
Publié: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
par: Afra, Sumaiya
Publié: (2022)

Marine compounds in the treatment of Alzheimer’s disease
par: Parveen, Sanjana
Publié: (2022)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
par: Halim, Rabea
Publié: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
par: Aana, Afsara Sumon
Publié: (2021)

Exploring Alzheimer's disease prediction with XAI in various neural network models
par: Rahman, Quazi Ashikur, et autres
Publié: (2022)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
par: Mostofa, Golam
Publié: (2022)

Gene editing for neurodegenerative diseases-A review
par: Sharna, Anika Islam
Publié: (2023)

A review on adult neurogenesis in Alzheimer’s disease
par: Akter, Moriam
Publié: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
par: Zaman, Rubaiyat
Publié: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
par: Haque, Mushfiqul
Publié: (2019)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
par: Roy, Aditya, et autres
Publié: (2023)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
par: Dey, Manashi
Publié: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
par: Sani, Mehedi Hasan, et autres
Publié: (2022)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
par: Alam, Badrul, et autres
Publié: (2016)

Role of circular RNA in neurological disease
par: Salsabil, Labiba
Publié: (2024)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
par: Mahbub, Riasat, et autres
Publié: (2022)

Skeleton /
par: Parkin, Peter

A review on interrelation among post-authorisation study, regulatory action and pharmacogenetics in pharmacovigilance
par: Nusrat, Tanzina
Publié: (2019)

হার্ট, ব্লাড, ফুড /
par: কাসেম, এম এ

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
par: Rahman, Ahadina
Publié: (2018)

Management of Diabetes patients during COVID-19
par: Pantho, G. M. Golam Mehebub
Publié: (2021)

Pharmacoepidemiology and pharmacovigilance : synergistic tools to better Investigate drug safety /
par: Nour, Sabrina
Publié: (2019)

Detection of alzheimer's disease using deep learning
par: Hasan, Mahmudul, et autres
Publié: (2021)